fbpx

Ware Malcomb, an award-winning international design firm, announced that construction is complete on DECISIO Health, located at 520 Post Oak Blvd. Suite 600, in Houston. Ware Malcomb provided interior architecture and design and branding services for the 15,000-square-foot interior office renovation.  DECISIO Health is a Houston-based digital health company with a configurable clinical decision support platform designed to aggregate data from electronic health records, in-room medical devices such as monitors and ventilators, and other sources of patient data to present relevant clinical data of the patients’ condition in a set of configurable dashboards. DECISIO Health, relocated to a new office space designed to enhance employee collaboration and create a thoughtfully designed work environment. The new office space, strategically selected for its suitability and capacity to accommodate DECISIO’s growing team, reflects the company’s commitment to fostering an energized and collaborative work environment. The office design seamlessly combines functional spaces with elements that evoke a techy, fun, speakeasy feel. A neutral, darker color palette paired with ample natural daylight and a variety of textures was chosen to create an engaging space custom designed to align with their company culture.   Ware Malcomb collaborated closely with DECISIO to bring their new office to life. The team addressed the unique challenges of...

HOUSTON, Sept. 13, 2022 /PRNewswire/ -- Last month the Houston Business Journal announced DECISIO Health as a recipient of the Innovation Awards. The award honors Houston's most innovative companies at the fourth annual Innovation Awards. More than just a startup/tech awards program, Houston Business Journal recognizes innovation across all industries and all facets of business. The evaluation criteria ensures that all companies, regardless of industry, domain or innovation type can clearly communicate, affirm and support their nomination. DECISIO Health will be featured in a special section of the Houston Business Journal's September 23rd weekly edition. DECISIO recently gained a patent related to a computer program product providing a novel patient dashboard system in a hospital setting. The flagship product, InsightIQ™, reduces clinical variation, improves outcomes while decreasing costs with digitized bundles of care that prioritizes clinicians' attention to at-risk patients requiring early intervention.  "We are excited and honored to receive this award. We feel this reflects the passion our company has for improving patients' outcomes and our customers' confidence in our products." said Co-CEO Dr. John Holcomb. About DECISIO ® DECISIO is a Houston-based digital health company with a customizable clinical decision support platform designed to aggregate and prioritize near real-time data, from any device, and present it visually in one place. The...

Houston-based Decisio Health wants to expand its platform to more hospital systems using new funding. The health technology firm recently closed a Series B fundraising round at $18.5 million, bringing Decisio's total funds raised to $31.5 million to date. David Moxam, executive chairman at Decisio, said the majority of the firm's existing stakeholders reinvested in Decisio's latest fundraising round. Using proceeds from the fundraising round, Decisio aims to roll out its real­ time patient monitoring platform with more large health care systems, Moxam said. Read the full article in the Houston Business Journal: https://www.bizjournals.com/houston/news/2022/04/11/decisio-health-patient-monitor-tech-fundraising.html ...

HOUSTON, TX, March 8, 2022 – DECISIO®, a company creating customizable clinical decision support tools to present real-time data across adaptable interfaces, has added a new product named EnvisionIQ™. This solution offers templated real-time and customized compliance reports to improve operational efficiency.  EnvisionIQ is a hospital’s solution to visualize critical patient outcome datasets across all bundles of care and service lines in real-time. The proprietary product helps hospitals unlock clinical data at the minutiae level in order to identify meaningful process change and work-flow improvements, leading to a reduction in complications, readmission rates.  EnvisionIQ enables a health system to benchmark their clinicians, units, and hospitals to accelerate improvements, reduce variation, and expedite data collection for agency reporting requirements.     “Clinical benchmarking tools are essential to enable health systems to quickly identify improvement opportunities that have substantial impact. The addition of EnvisionIQ to our product portfolio allows DECISIO to provide comprehensive surveillance and analytics platforms to benefit hospitals in many capacities,” said Paul Sinclair, Chief Revenue Officer at DECISIO.    EnvisionIQ provides insights into current care patterns, protocol compliance, areas for workflow improvement, and analysis of clinical datasets.  It works across various diagnosis and care bundles, including Ventilator, Stroke, and Sepsis Management, plus many more. The...

DECISIO®, a company creating customizable clinical decision support tools to present near real-time data across adaptable interfaces, has added a new product named EnvisionIQ™. This solution offers on demand compliance reports to improve operational efficiency.  EnvisionIQ is a hospital’s solution to visualize critical patient outcome datasets across all bundles of care and service lines. The proprietary product helps hospitals unlock clinical data at the minutiae level in order to identify meaningful process change and work-flow improvements, can lead to a reduction in complications, readmission rates.  EnvisionIQ enables a health system to benchmark their clinicians, units, and hospitals to accelerate improvements, reduce variation, and expedite data collection for agency reporting requirements.     “Clinical benchmarking tools are essential to enable health systems to quickly identify improvement opportunities that have substantial impact. The addition of EnvisionIQ to our product portfolio allows DECISIO to provide comprehensive surveillance and analytics platforms to benefit hospitals in many capacities,” said Paul Sinclair, Chief Revenue Officer at DECISIO.    EnvisionIQ provides insights into current care patterns, protocol compliance, areas for workflow improvement, and analysis of clinical datasets.  It works across various diagnosis and care bundles, including Ventilator, Stroke, and Sepsis Management, plus many more. The product has three levels of capabilities: Essential, Essential...

Decisio Health believes that now, more than ever,  our technology, which is a decision support device indicated for aggregating, displaying and managing physiological and other patient information, is an important part of helping to deliver the best care to COVID-19 patients during this pandemic when hospitals are at their busiest.  As a company, we are providing support to the University of Arkansas for Medical Sciences (UAMS) by assisting with their most urgent clinical needs through innovation. Our partnership is making an impact through monitoring of critical patients and their response to therapy, expanded patient surveillance, and supporting COVID-19 research. UAMS has treated over 800 COVID-19 patients to date and while the pandemic continues to disrupt the world we live in, their infection prevention and dedicated hospitalist teams are working tirelessly to treat this unique group of patients. It is no surprise that this pandemic is a constant stressor to those on the front lines and we aim to lessen the burden on clinicians by extending the capability of our software to help them care for patients during these exhausting times. Our robust monitoring and data visualization provides increased patient awareness for potentially faster decision making in each intensive care unit at...

GE Healthcare today announced its investments in and collaborations with Formlabs, CMR Surgical Ltd. and Decisio Health, companies specializing in 3D printing, surgical robotics and virtual care monitoring respectively. When paired with GE Healthcare’s diagnostic expertise and global scale, these three novel healthcare technologies will help expand clinical capabilities and enable more effective diagnosis, treatment and monitoring of patients. “Healthcare’s next chapter will be written in part by emerging technologies like 3D printing, robotic surgery and virtual patient monitoring,” said Kieran Murphy, president and CEO of GE Healthcare. “That’s why we’re putting GE Healthcare’s innovative engine and resources behind collaborations with these exciting, next generation companies – to help change the way clinicians work and enable more precise patient care.” 1. GE Healthcare is collaborating with Formlabs, a Massachusetts-based manufacturer of advanced, affordable 3D-printers that can help clinicians easily and quickly print anatomical models at the point of care. These tangible models accurately visualize patient anatomy and disease for improved communication within the medical team, better hands-on case-based teaching models and enhanced patient education. Radiologists can use GE Healthcare’s Advantage Workstation to prepare 3D CT or MRI data to assist in diagnosis and procedure planning, then export using 3D Suite in a...

How Digitizing Protocols, Care Pathways, and Best Practices Helps Clinicians Save Lives. One-third of hospitalized sepsis patients die, according to research published in 2017 in JAMA: The Journal of the American Medical Association. Yet there’s recent research that suggests use of early goal-directed therapy, or EGDT, in the emergency department care of patients with severe sepsis and septic shock can save lives.[1] But translating research knowledge and patient information into clinical practice pathways can be complex, time-consuming and resource-exhausting, especially in hospitals already facing challenges that can lead to variation in care at the department level or even throughout the enterprise. Not surprisingly, those challenges can lead to significant consequences for the patient experience and outcomes, including incidence of sepsis, readmission, length of stay and more. This is where digitizing hospital-proven care pathways may hold the power to help beat the odds. “Applying digital capabilities can give the clinician a flashlight for peering into tons of data, which could reveal potentially life-saving insights,” explained Vivek Bhatt, chief technology officer, GE Healthcare Clinical Care Solutions. “Without visibility, how can a clinician begin to see the whole picture?” Digitizing may lead to more compliant care, which translates into improved patient outcomes, including lives saved. A 10% increase in compliance to...